TET2 and acute myeloid leukemia: We observed that mutations of DNA methylation-related genes occurred in 62% NRASmut AML, the most common of which is TET2. This indicated that DNA methylation may play an important role in the pathogenesis in NRASmut AML and provided a basis for demethylation treatment of NRASmut AML patients.